3004.10.50.55/Amoxicillin-Clavulanate 600mg/5mL Oral Suspension/Japan

Amoxicillin-Clavulanate 600mg/5mL Oral Suspension from Japan

Combination powder for oral suspension with amoxicillin and clavulanic acid (beta-lactamase inhibitor) for resistant infections like sinusitis. Still classified in HTS 3004.10.50.55 as primarily penicillin-based for oral suspension in therapeutic doses.

Duty Rate — Japan → United States

0%

Rate breakdown

9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Calculate with your customs valueVerify classification with AI

Import Tips

• Declare clavulanate content accurately; ensure dual-API stability testing

• Pitfall: confusing with plain amoxicillin headings